Urolithin A for Athletes: Performance & Recovery

Athletes chase the same thing at every level: more work capacity, faster recovery between sessions, and muscles that keep answering the call late in a block. Urolithin A is one of the few longevity-adjacent compounds with human performance data behind it, and this guide lays out honestly what that evidence does and does not show.

Why mitochondria are the athlete's real bottleneck

Every contraction you make is paid for in ATP, and nearly all of that ATP is produced inside mitochondria, the small organelles packed into your muscle fibers. When you train hard, you place enormous demand on this machinery, and some of those mitochondria become damaged or inefficient over time. Your cells have a built-in quality-control process called mitophagy: worn-out mitochondria are tagged, broken down, and recycled so that healthier, better-functioning ones can take their place. Efficient mitophagy is part of what keeps a muscle metabolically 'young,' and it is one reason a well-trained aerobic system can sustain output that a deconditioned one cannot.

Urolithin A is interesting to athletes precisely because it acts on this recycling step. It is a gut postbiotic: your microbiome makes it from ellagitannins found in pomegranate, walnuts, and certain berries. The catch is that only some people carry the microbial species needed to convert those precursors efficiently, so eating pomegranate does not guarantee meaningful urolithin A exposure. A standardized supplement sidesteps that lottery by delivering the finished molecule directly. Foundational preclinical work by Ryu and colleagues in 2016 (Nature Medicine) first showed that urolithin A stimulated mitophagy and improved muscle function in rodents and extended lifespan in C. elegans. That work is mechanistic and animal-based, so treat it as the rationale, not as proof of a performance effect in trained humans.

The human performance evidence, organized by strength

What separates urolithin A from most 'mitochondrial' supplements is that the human trials actually exist. They are still short and modestly sized, but they are real randomized studies, and it is worth ranking them by how directly they speak to athletes.

Strongest human signal: strength and exercise performance

Singh and colleagues (2022, Cell Reports Medicine) ran a four-month randomized trial in middle-aged adults with 500 mg and 1,000 mg daily arms. They reported improvements in measures of muscle strength and exercise performance versus placebo. This is the most performance-relevant human dataset to date, and notably it used the same daily amounts you see in standardized products today. The participants were not elite athletes, so the honest read is that urolithin A supported the muscle-performance capacity of ordinary adults over a training-length window.

A separate four-month trial by Liu, D'Amico and colleagues (2022, JAMA Network Open) in older adults measured muscle endurance as the number of contractions performed before fatigue and found benefit alongside favorable shifts in mitochondrial and cellular markers. Again, an older population, but endurance-to-fatigue is a metric every athlete respects.

Newer human data closer to the training population

More recently, an 8-week randomized controlled trial in resistance-trained men (2024, Journal of the International Society of Sports Nutrition) examined urolithin A in people who already lift seriously. It looked at endurance and recovery-related markers over the training block. This is the first study to put the compound in front of a genuinely trained cohort, and while it is one study of modest size, it moves the evidence meaningfully closer to the gym floor. The first-in-human safety study by Andreux and colleagues (2019, Nature Metabolism) underpins all of this: urolithin A was safe and well tolerated at doses up to 1,000 mg per day and produced a measurable mitochondrial gene-expression signature in humans.

Recovery and inflammation: a reasonable, still-early rationale

Hard training transiently increases oxidative stress and low-grade inflammation, and part of feeling recovered is how quickly that internal environment settles. Because urolithin A works upstream on mitochondrial quality, researchers have looked at recovery-adjacent and inflammatory markers rather than soreness alone. A 2025 Nature Aging randomized trial (roughly 28 days) reported that urolithin A supported the mitochondrial health of immune cells in midlife adults, in the context of what scientists call 'inflammaging.' That is an immune-cell and midlife-aging finding, not a claim about post-workout soreness, but it fits the broader picture that this compound acts on cellular energy systems that also influence the inflammatory response. Any effect here supports normal recovery processes; it is not a treatment for injury or for a medical inflammatory condition, and pain that is sharp, localized, or lingering deserves a clinician's eye rather than a supplement.

How athletes should dose it

The clinically studied range is 500 to 1,000 mg per day, with 1,000 mg sitting at the top of that range and matching the arm used in the strength and performance work. Urolithin A is taken daily, not just before a session, because it works by nudging an ongoing cellular housekeeping process rather than by acting as a stimulant. There is no pre-workout timing trick here; consistency across a training block is the mechanism. In the trials, benefits emerged over weeks to months, so set expectations accordingly and judge it across a full mesocycle, not a single week. For deeper specifics, see our urolithin A dosage guide and how to take urolithin A.

The clean-label question for tested athletes

If you compete under an anti-doping code, what goes in your body has to be traceable. Urolithin A itself is a food-derived metabolite, not a stimulant or a banned class, but the practical risk with any supplement is contamination and label accuracy, not the headline ingredient. That is why third-party testing matters more than marketing: it verifies identity, dose, and purity. The SOMA HEALTH gummies are third-party tested and sugar-free, which also keeps them friendly to athletes managing carbohydrate timing or dental load from frequent fueling. As always, if you are subject to formal testing, clear any new supplement with your team's medical or compliance staff first.

Honest limitations

A 2024 systematic review in Ageing Research Reviews on targeting aging with urolithin A in humans reached a measured conclusion: the human evidence is still emerging, the trials are short, and the sample sizes are modest. That is the right frame. Urolithin A is not a substitute for training, sleep, or adequate protein and total energy, and it will not turn a recreational athlete into an elite one. What the data supports is a plausible, well-tolerated tool that acts on a genuine performance bottleneck, best judged over months. If you want the broader picture beyond sport, our complete urolithin A guide, our roundup of the best urolithin A gummies, and our summary of the clinical studies go deeper.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This guide is educational and is not a substitute for advice from a qualified healthcare provider.